Health
Double antibody against SARS-CoV-2 prevents therapy-resistant variants – Medical Xpress
An international consortium that includes researchers at Karolinska Institutet has developed a double antibody that targets two sites of the SARS-CoV-2 virus, thereby…
An international consortium that includes researchers at Karolinska Institutet has developed a double antibody that targets two sites of the SARS-CoV-2 virus, thereby preventing the virus from mutating to resist the therapy. A study published in the scientific journal Nature shows that the antibody potently neutralizes SARS-CoV-2 and its variants and protects against COVID-19 in mice.
Antibody-based immunotherapy has already been shown to be effective against COVID-19 but faces two main obstacles;…
-
General13 hours agoUber driver says rideshare app tells workers to flout road rules as bill introduced
-
General9 hours agoPerson in potentially life-threatening condition after wall collapses in Brisbane’s West End
-
Noosa News5 hours agoPolice appealing for information about ‘suspicious’ Brisbane charity fire that killed 44-year-old man
-
General14 hours agoBoard stacking allegations as RACP directors call snap meeting